梁雷锋, 衷敬华, 严浩林, 甘媚, 林展, 朱海生. 沙利度胺防治鼻咽癌放射性口腔黏膜炎的疗效观察[J]. 中国肿瘤临床, 2017, 44(23): 1189-1193. DOI: 10.3969/j.issn.1000-8179.2017.23.587
引用本文: 梁雷锋, 衷敬华, 严浩林, 甘媚, 林展, 朱海生. 沙利度胺防治鼻咽癌放射性口腔黏膜炎的疗效观察[J]. 中国肿瘤临床, 2017, 44(23): 1189-1193. DOI: 10.3969/j.issn.1000-8179.2017.23.587
shu
LIANG Leifeng, ZHONG Jinghua, YAN Haolin, GAN Mei, LIN Zhan, ZHU Haisheng. The efficacy of thalidomide on preventing and treating radiation-induced oral mucositis in nasopharyngeal carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 44(23): 1189-1193. DOI: 10.3969/j.issn.1000-8179.2017.23.587
Citation: LIANG Leifeng, ZHONG Jinghua, YAN Haolin, GAN Mei, LIN Zhan, ZHU Haisheng. The efficacy of thalidomide on preventing and treating radiation-induced oral mucositis in nasopharyngeal carcinoma[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 44(23): 1189-1193. DOI: 10.3969/j.issn.1000-8179.2017.23.587
shu

沙利度胺防治鼻咽癌放射性口腔黏膜炎的疗效观察

The efficacy of thalidomide on preventing and treating radiation-induced oral mucositis in nasopharyngeal carcinoma

    摘要
  • 摘要:
      目的   观察沙利度胺防治鼻咽癌(nasopharyngeal carcinoma, NPC)放射性口腔黏膜炎(radiation-induced oral mucositis, RIOM)的疗效。
      方法  2015年5月至2016年8月就诊于玉林市第一人民医院60例NPC患者随机分配进入试验组和观察组。试验组在放射治疗开始口服沙利度胺片, 并用生理盐水+庆大霉素+地塞米松混合液漱口, 对照组自放疗开始仅用生理盐水+庆大霉素+地塞米松混合液漱口。观察两组RIOM发生时间及程度。
      结果  试验组RIOM的发生率低于对照组, 差异具有统计学意义(P < 0.05), 试验组3、4级RIOM的发生率低于对照组, 差异具有统计学意义(P < 0.05)。两组客观缓解率差异无统计学意义(P> 0.05)；试验组和对照组口腔照射剂量体积在平均剂量、V30、V35、V40、V45、V50、V54方面差异均无统计学意义(P> 0.05)；试验组和对照组在营养制剂、激素、抗生素使用方面差异均无统计学意义(P> 0.05)；两组嗜睡、周围神经毒性、血液学毒性、胃肠道反应方面差异均无统计学意义(P> 0.05)。
      结论  沙利度胺可降低NPC的RIOM的发生率及严重程度。

     

    Abstract:
      Objective  To evaluate the efficacy and safety of thalidomide on preventing and treating radiation-induced oral mucositis (RIOM) in nasopharyngeal carcinoma(NPC).
      Methods  A total of 60 patients with NPC were randomly divided into treatment group and control group.The treatment group took thalidomide and gargled with mixture of saline+gentamycin + dexamethasone when radiotherapy started, and the control group gargled only with mixture of saline+gentamycin+dexamethasone.The time of occurrence and degree of RIOM in both groups were registered at the same time.
      Results  The incidence of RIOM in treatment group was lower than that in control group(P < 0.05).For the incidence of 3 or 4 grade RIOM, the treatment group was also lower than the control group.No statistical difference in terms of objective response rate was found between the two groups(P> 0.05).There was no statistically significant difference between the treatment group and the control group in the oral average dose, V30, V35, V40, V45, V50, and V54(P> 0.05).There was no statistically significant difference between the treatment group and the control group in the use of nutrition agents, hormones and antibiotics(P> 0.05).There was no statistical difference between the groups in the drowsiness, peripheral nerve toxicity, hematologic toxicity and gastrointestinal reaction(P> 0.05).
      Conclusion  Thalidomide can reduce the incidence and severity of RIOM for radiotherapy of patients with NPC, which deserves clinic application.

     

    • HTML全文
    • 参考文献(16)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回